InvestorsHub Logo
Followers 572
Posts 9510
Boards Moderated 1
Alias Born 09/03/2004

Re: None

Thursday, 06/07/2018 2:15:38 PM

Thursday, June 07, 2018 2:15:38 PM

Post# of 49606
CELZ- Yesterday announced Dr Timothy Henry, Expert in stem cells and Cardiologist at Cedar Sinai joined the CELZ Scientific Board.

CELZ owns key patent for cardiology stem cell treatment and is already implementing rollout of their stem cell ED treatment. They are soliciting, evaluating and enrolling Urologists for exclusive 50 mile treatment zones in the US. The stem cell centrifuge is FDA approved, the kit sold is FDA approved and the process is exempt from FDA approval because the bone marrow is withdrawn, stem cells separated and injected in the same procedure of about 45 minutes. Clinical results due in August as well. I wonder why a key Cardiologist with stem cell background would come aboard about now if results aren't very good?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.